Medical marijuana is not proven to treat neuropathy. Trials report mixed results. No cannabis product holds FDA approval for nerve pain. Evidence is strongest for chronic pain in general and weaker for nerve pain caused by diabetes or chemotherapy. Two synthetic THC drugs, dronabinol and nabilone, are approved for nausea and weight loss, not for neuropathy.
What neuropathy is
Peripheral neuropathy damages nerves outside the brain and spinal cord. Symptoms include numbness, tingling, burning, sharp pain, and weakness. Feet and hands feel it first. About 2.4% of people have the condition. Rates climb to 8% after age 55. Diabetes is the top cause in the US. About half of people with diabetes develop nerve damage over time. Other causes: chemotherapy, heavy alcohol use, vitamin B12 deficiency, HIV, kidney disease, and hypothyroidism. About 30% of cases have no identified cause.
What the research shows
A 2017 National Academies review covered more than 10,000 studies. It found substantial evidence that cannabis reduces chronic pain in adults. Evidence for neuropathy alone was limited.
best medical cannabis strains for neuropathy
A 2014 American Academy of Neurology guideline matched that pattern. Oral cannabis extract was possibly effective for central pain from multiple sclerosis. Evidence for peripheral neuropathy was insufficient.
Trials of nabiximols, an oral THC and CBD spray, tested diabetic nerve pain. Results varied. Many studies enrolled fewer than 50 people and ran 2 to 12 weeks. A 2021 review rated the evidence for cannabis-based medicines in nerve pain as low certainty.
CBD alone has few human trials for neuropathy. Most data come from animal models. Researchers do not know an effective CBD dose for nerve pain.
Dosing and product forms
No standard dose exists for neuropathy. Dispensary products vary in THC and CBD content, and lab tests find label errors. Trials used THC starting doses of 1 mg to 5 mg per day, with some patients reaching 30 mg. CBD trials for other conditions used 5 mg to 50 mg per day.
- Inhaled: effects start in minutes and last 2 to 4 hours.
- Oral: effects start in 30 to 90 minutes and last 4 to 8 hours.
- Topical: little THC reaches the bloodstream. Evidence for pain relief is thin.
Side effects and drug interactions
Common THC effects: dizziness, drowsiness, dry mouth, poor balance, and short-term memory problems. THC raises heart rate. It can trigger anxiety or psychosis in people with a personal or family history.
CBD blocks the liver enzymes CYP2C19 and CYP3A4. That can raise blood levels of clobazam, warfarin, tacrolimus, and some statins. THC adds sedation when combined with opioids, benzodiazepines, or alcohol.
Legal status in the US
38 states and Washington, DC run medical cannabis programs. Cannabis remains Schedule I under federal law, so state and federal rules conflict. Medical programs require a qualifying diagnosis and a clinician certification. Hemp-derived CBD with less than 0.3% delta-9 THC is legal under the 2018 Farm Bill.
Questions for a clinician
- What caused my neuropathy?
- Which treatments have the strongest evidence for my type?
- Could cannabis interact with my current drugs?
- What dose and form should I try first?
- How will we track whether it helps?
Bottom line
Cannabis may ease chronic pain for some people. Proof for neuropathy is thin. Talk with a clinician before you start. Treat it as a trial with a set dose and a set review date.